The 100 most-cited articles on cardiovascular diseases from Mainland China by unknown
RESEARCH ARTICLE Open Access
The 100 most-cited articles on
cardiovascular diseases from Mainland China
Yuan-hui Liu1†, Sheng-qi Wang2†, Jin-hua Xue3,4†, Yong Liu1, Ji-yan Chen1, Guo-feng Li2 and Ning Tan1*
Abstract
Background: China, as a rapidly developing country with the largest population of cardiologist in the world, has
an increasing importance in the field of cardiology. However, the quantity and quality of research production in
the field of cardiology is unclear.
Aims: To analyze the characteristics of the high-level articles published on cardiovascular diseases in Mainland
China, and to provide information about achievements and development in cardiovascular research.
Methods: We searched the Science Citation Index Expanded for citations of cardiovascular articles originating in
mainland China from 2004 to 2015. For the 100 most frequently cited articles (T100), we evaluated the number of
citations, publication time, province of origin, journal, impact factor, topic or subspecialty of the research, and
publication type.
Results: The most frequently cited article received 703 citations at the most, while 50 at the least (mean 91.6 citations
per article). T100 originated from 16 provinces, the plurality (n = 34) being from the Beijing. Sixty-seven percent were
published during 2006–2009. The publications were in 29 different journals of which Circulation published the most
(n = 14). Leading general medical journals Journal of the American Medical Association (n = 1), Lancet (n = 0) and New
England Journal of Medicine (n = 0) featured only 1 published article, despite their extremely high impact factors. Of
the T100 articles, there were 50 basic researches, 44 clinical researches, 5 meta-analyses and 1 review article. Clinical
researches had the highest mean citations (mean 102.6 citations per article).
Conclusions: This study provides a historical perspective on the scientific progress, and the trends in cardiovascular
medicine in Mainland China.
Background
Citation analysis is one of the most widely employed
methods of bibliometrics. It is used to determine the
impact factor (IF) of a journal and useful for evaluating
the impact of an article on the scientific community.
Academic institutions, funding agencies, and the public
are now increasingly interested in assessing the
research quality and productivity of individual re-
searchers by citation analysis [1]. Therefore, there have
been numerous attempts to identify the most highly cited
articles in various medical specialties including traumatic
brain injury [2], radiology [3], hypospadiology [4], micro-
surgery [5], orthopaedic surgery [6], hypertension [7] and
cardiac surgery [8].
Cardiovascular disease has evolved substantially in
the last few decades. It is becoming an increasingly
common disease in China, which, with more than 1.3
billion citizens, is the world’s most populous developing
country. As China has grown economically, it has expe-
rienced an epidemiological transition, with mortality
due to cardiovascular diseases, such as ischaemic heart
disease, more than doubling during the past two
decades to more than 1 million deaths per year [9]. Re-
search originating from Mainland China related to car-
diovascular diseases has made great advances in recent
decades, gaining increasing importance and attention
in the world community. However, there is still a lack
of knowledge regarding the quality of the scientific
yield in this area. Therefore, the present study aimed to
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analyze the characteristics of the 100 top-cited articles
published on cardiovascular diseases in Mainland
China, and to provide information about achievements
and development in cardiovascular research over the
past ten years.
Methods
In March 2015, we performed a citation search for pub-
lished articles on cardiovascular diseases from 2004 to
2015, using the Science Citation Index Expanded of the
ISI Web of Science (Thomson Reuters, Philadelphia,
PA, USA). There were 107 journals in our investigation
under the subject category of “cardiology, cardiovascu-
lar, and heart.” in Journal Citation Reports for 2014. In
addition, we searched three leading clinical medicine
journals, the New England Journal of Medicine, the
Lancet, and the Journal of the American Medical Asso-
ciation. Finally, a total of 110 journals were used to
identify the most-cited articles in our study. There were
no restrictions on the study types, but only articles
written in the English language were included.
All included journals were collected in a single search
of the Web of Science. A filter for “Countries/territories”
was applied by selecting “Peoples R China” to include
articles originating only from Mainland China. After all
indexed published articles had been retrieved, the results
were sorted using the option “Times cited”, which pro-
vided us with a list of all the articles published in a
specific journal ranked by citation count. Each article
was then evaluated, and articles having first author and
first address in Mainland China were included, while
those that originated outside Mainland China, or had
one or more Chinese co-authors but not the first author
were excluded.
Of the total articles remaining, the top 100 accord-
ing to the number of citations (T100) were further
analyzed by two independent reviewers. Applying the
same methods used in previous similar studies [10],
the following data were compiled: journal name, title,
number of citations, decade published, number of au-
thors, publication year, impact factor, province of ori-
gin, and topic or subspecialty of the research. In
addition, two independent reviewers reviewed titles
and abstracts to determine the study types: meta-
analysis, basic research, or clinical research (observa-
tional or randomized control trials). Another reviewer
resolved any disagreements regarding article eligibility.
We also reviewed the association between journal IF
and the number of articles, and the numbers of cita-
tions included in the top 100 articles. The IFs of the
journals were cross-referenced with the 2014 edition
of Journal Citation Reports (JCR): Science Edition
(1945–2013).
Statistical analysis
Data were expressed as median and interquartile range.
The Wilcoxon rank sum test was performed to evaluate
differences between groups. The Spearman test was used
to evaluate the strength and direction of the linear rela-
tion between the IF of the journal and the numbers of
top 100 cited articles or citations included in the list. All
data analyses were performed using SAS, version 9.2
(SAS Institute, Cary, NC, USA). All probability values
were two-tailed, and the statistical significance was
defined as p < 0.05.
Results
The T100 articles are listed in Table 1 and Additional
file 1. (1–20 in Table 1; A complete list (21–100) is given
in Additional file 1 as supplementary data on-line). The
number of citations for the T100 articles ranged from 50
to 703, while only four papers were cited over 200 times.
Of the T100 articles, 67 % were published in the 4-year
period from 2006 to 2009 (Fig. 1), while none were pub-
lished in the latest three years (2013–2015). The mean
number of citations per year was 216 (range 161 to 266)
for these four years.
The T100 articles originated from 14 different prov-
inces of Mainland China, a plurality being from Beijing
(n = 34, 2928 citations), followed by Shanghai (n = 15),
Zhejiang (n = 7), Shanxi (n = 7), Hubei (n = 6), and
Guangdong (n = 5), while the remaining provinces had
<5 highly cited articles (Fig. 2a-b). Articles originated
from Shanghai had the highest mean citations (mean
105.6 citations per article).
The leading first author, with 703 citations, was Chen
SL, the next 4 were Wang GK (n = 346), Liu J (n = 273),
Hu XY (n = 207), and Zhang QJ (n = 165). Among the
T100 articles, most of the authors had just 1 highly cited
article, and only Chen SL, had 3 highly cited articles as
the first author, with a mean of 273 citations.
The T100 articles were published in 29 different jour-
nals. The journal with the highest number of T100 arti-
cles was Circulation (n = 14), followed by Cardiovascular
Research (n = 10), Journal of the American College of
Cardiology (n = 10), Atherosclerosis (n = 7), Circulation
Research (n = 7), European Heart Journal (n = 7), and
International Journal of Cardiology (n = 6). However, the
general medical journals, Journal of the American Med-
ical Association (n = 1), Lancet (n = 0) and New England
Journal of Medicine (n = 0) featured only 1 article in the
list, despite their extremely high IFs. The IFs for the
journals that published the T100 articles ranged from
1.1 to 30.4. Many of the T100 articles were published in
high- IF journals (Table 2), while the journal IF was
significantly correlated with the number of T100 articles
(r = 0.51, p = 0.004), and the number of citations (r = 0.58,
p = 0.001).
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The analysis of the design of the T100 articles found that
they included 6 meta-analyses and 1 review, whereas the
majority of the article types were basic science studies (50
articles), followed by clinical trials (43 articles) (Fig. 3).
Among the 43 clinical articles, 13 were randomized
clinical trials and 30 were observational trials. As shown
in Fig. 4, these clinical trials were mainly focused on cor-
onary artery disease (21 studies, including 6 on acute cor-
onary syndromes), epidemiology (4 studies), arrhythmia
(4 studies), cardiac surgery (3 studies), heart failure
Table 1 Bibliometric information associated with the Top 20 of the Top 100 most frequently cited articles on cardiovascular diseases
(T100) from mainland china
Rank Author Title Journal Year Times
Cited
PMID
1 Chen, SL et al. Effect on left ventricular function of intracoronary transplantation
of autologous bone marrow mesenchymal stem cell in patients




2 Wang, Guo-Kun et al. Circulating microRNA: a novel potential biomarker for early
diagnosis of acute myocardial infarction in humans
European Heart Journal 2010 346 20159880
3 Liu, J et al. Predictive value for the Chinese population of the Framingham






4 Hu, Xin yang et al. Transplantation of hypoxia-preconditioned mesenchymal stem
cells improves infarcted heart function via enhanced survival of
implanted cells and angiogenesis
Journal of Thoracic and
Cardiovascular Surgery
2008 207 18374759
5 Zhang, Qing-jun et al. Endothelium-specific overexpression of class III deacetylase SIRT1




6 Wu, Yang feng et al. Prevalence, Awareness, Treatment, and Control of Hypertension in
China Data from the China National Nutrition and Health Survey 2002
Circulation 2008 158 19106390
7 Ma, J et al. Time course of myocardial stromal cell-derived factor 1 expression
and beneficial effects of intravenously administered bone marrow




8 Xu, FP et al. Leptin induces hypertrophy via endothelin-1-reactive oxygen
species pathway in cultured neonatal rat cardiomyocytes
Circulation 2004 154 15313952
9 Li, Xiao Hong et al. Bone marrow mesenchymal stem cells differentiate into functional




10 Wang, TZ et al. Cell-to-cell contact induces mesenchymal stem cell to differentiate




11 Liu, Tong et al. Association between C-reactive protein and recurrence of atrial





12 Wan, Yi et al. Anticoagulation Control and Prediction of Adverse Events in





13 Ge, J. et al. Efficacy of emergent transcatheter transplantation of stem cells for
treatment of acute myocardial infarction (TCT- STAMI)
Heart 2006 127 16775089
14 Hou, Ying long et al. Ganglionated plexi modulate extrinsic cardiac autonomic nerve
input-Effects on sinus rate, atrioventricular conduction,





15 Shan, Hong li et al. Downregulation of miR-133 and miR-590 contributes to nicotine-




16 Hu, Da-Yi et al. The relationship between coronary artery disease and abnormal
glucose regulation in China: the China Heart Survey
European Heart Journal 2006 115 16984927
17 Min, TQ et al. Improvement in endothelial progenitor cells from peripheral blood




18 Lu, Yan jie et al. MicroRNA-328 Contributes to Adverse Electrical Remodeling in
Atrial Fibrillation
Circulation 2010 112 21098446
19 Wang, LH et al. TRPV1 gene knockout impairs postischemic recovery in isolated
perfused heart in mice
Circulation 2005 111 16314376
20 He, Y et al. Prevalence of the metabolic syndrome and its relation to
cardiovascular disease in an elderly Chinese population
Journal of The American
College of Cardiology
2006 110 16630995
Note: See Additional file 1 for the other 80 articles of the T100
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(2 studies), hypertension (2 studies), congenital heart
disease (1 study), or other topics (6 studies). In terms of
time, 5 earliest clinical researches which were published in
2004 were cited the most (239 times per article), while 3
earliest basic researches in 2004 were cited the most (110
times per article) (Fig. 5).
The number of total citations per article ranged from
50 to 703 (mean, 102.6) for clinical articles, and 52 to
207 (mean, 83.8) for basic science. Among the articles
with >100 citations, the most common topics were acute
myocardial infraction (n = 3, 27.3 %) for clinical articles
and stem cells (n = 4, 33.3 %) for basic science.
Discussions
The present study is the first to identify, rank and
characterize the T100 cited articles from the past ten
years in Mainland China in the field of cardiovascular
disease. The results offer invaluable insight into the evo-
lution of popular opinion in the field of cardiovascular
disease, which has undergone considerable change over
the years around the world.
Citation analysis can reflect the articles’ influence in a
specific field, help authors recognize important advances
in some research area, and add useful perspective on
historical developments in our specialty. In addition,
journals often use it to attract manuscripts with high cit-
ation potential. Furthermore, an understanding of the
characteristics inherent to highly cited work would be
helpful for young researchers who wish to publish effect-
ively. To date, there are increasing numbers of articles
credited as “the most cited” or “top cited” in various
medical fields. According to a report on Chinese Cardio-
vascular Disease in 2013, there were approximately 2.9
billion patients with cardiovascular diseases, and the
associated mortality increased from 240.03/10 million in
2004 to 268.9/10 million in 2010 [11]. However, there is
little information in the literature concerning the cit-
ation of articles about cardiovascular diseases in China.
Recently, Shuaib et al. conducted a study to provide
insight into the citation frequency of top cited articles
published in cardiovascular medicine [12]. Unfortu-
nately, however, no cardiovascular articles from China
were included in that analysis. Therefore, it is necessary
to analyze the top article citations in cardiovascular dis-
ease from Mainland China in the past ten years, which
has seen great advances and changes in cardiovascular
diseases over that period, to help readers or authors
recognize the quality of the research work, discoveries,
and the trends steering cardiology.
Fourteen cities contributed to the T100 cited articles,
led by Beijing, the capital of China, followed by Shang-
hai. This confirms the important influence of both cities
in relation to cardiovascular diseases and research in
Mainland China. This was in concordance with many
other citation analyses of other medical specialties from
Mainland China, which reported that most studies that
made the T100 list came from Beijing or Shanghai. The
Fig. 1 Numbers of articles published in each year and the
corresponding numbers of citations in each year
Fig. 2 The T100 articles were analyzed in terms of their origin province. a: Numbers of articles in each province. b: Numbers of citations for the
articles in each province
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reason for this may be that these two cities have large
numbers of cardiovascular communities and sufficient
financial support from the country to perform basic or
clinical research.
The IF represents the citation frequency of the average
article published in a given journal in a particular year,
and is always used to determine the quality of scientific
or biomedical journals. Authors would prefer to send
their research papers to journals with a high IF. In turn,
this gives those journals a greater chance to receive high
quality research articles, which will be cited more fre-
quently after being published [13–15]. In accordance
with the research performed by Shuaib et al. [12], we
also demonstrated that the IF was positively correlated
with the number of T100 articles, and the number of
citations. Although the evaluation of journals based on
their IF involves potential bias and is under debate, there
is presently no perfect or even better method for evalu-
ating the merit of a scientific paper, and the IF and
citation total are generally accepted as the best criteria.
Our results demonstrated that 38 % of these T100
cited articles were published in Circulation, the Journal
of the American College of Cardiology, Circulation
Research, or the European Heart Journal, all of which
had an IF >11. However, the so-called high IF general
medical journals, such as the Journal of the American
Medical Association, The Lancet and The New England
Journal of Medicine, only contributed 1 article to the list
of T100 articles. In addition, journals with relatively
lower IF also published highly cited articles (e.g. the 1st
Table 2 Journals in which the T100 articles were published
Journal No. of Articles (Citations) Impact Factor
Circulation 14(1308) 14.9
Cardiovascular Research 10(787) 5.81
Journal of the American College of Cardiology 10(743) 15.34
Atherosclerosis 7(631) 3.97
Circulation Research 7(483) 11.09
European Heart Journal 7(795) 14.72
International Journal of Cardiology 6(454) 6.18
journal of molecular and cellular cardiology 5(377) 5.22
Journal of Cardiovascular Electrophysiology 4(287) 2.88
American Heart Journal 3(210) 4.56
European Journal of Cardio-Thoracic Surgery 3(199) 2.81
American Journal of Cardiology 2(789) 3.43
American Journal of Physiology-Heart and
Circulatory Physiology
1(71) 4.01
Basic Research in Cardiology 2(239) 5.96
Heart 2(204) 6.02
JACC- Cardiovascular Interventions 2(111) 7.44
Journal of Cardiovascular Pharmacology 2(156) 2.11
Journal of Thoracic and Cardiovascular Surgery 2(292) 3.99
Annals of Thoracic Surgery 1(51) 3.63
Cardiology 1(85) 2.04
Cardiovascular Drugs and Therapy 1(115) 2.95
Circulation- Arrhythmia and Electrophysiology 1(61) 5.42
Circulation- Cardiovascular Quality and Outcomes 1(127) 5.04
Clinical Cardiology 1(53) 2.23
Heart Rhythm 1(63) 4.92
International Heart Journal 1(102) 1.13
JAMA- journal of the American Medical Association 1(273) 3.39
Journal of Electrocardiology 1(63) 1.36
Pediatric Cardiology 1(57) 1.55
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and 24th T100 journals, with IF of 3.4 and 5.8 respect-
ively). This indicates a growing trend towards publishing
highly influential articles in specialty journals that are
dedicated solely to research into cardiovascular diseases,
rather than in general medical journals. The present
result was in accordance with other bibliometric analyses
demonstrating that highly influential reports are often
published in specialty journals [16–18].
Generally, with increasing age, each article has more
time to be cited, but in this analysis, most of the T100
articles (67 %) were published between 2006 and 2009.
Among the articles with >100 citations, 62 % were pub-
lished during this period. The present result was in
agreement with the recent research by Shuaib et al. [12].
Those investigators indicated that 42 % of the T100 cited
articles, a lower percentage than for articles from China
in the same period, were published between 2006 and
2010 around the world; however, their results excluded
research articles from China.
Among the clinical articles, it was observed that a
large majority of the most highly cited articles in cardio-
vascular medicine were focused on coronary artery
disease. This was in accordance with the morbidity of
CAD according to the report on Chinese Cardiovascular
Disease in 2013 [11], which demonstrated that in the
past 10 years, the mortality of CAD continued to
increase, up to 96/10 million in urban and 76/10 billion
in rural areas. The high morbidity and mortality of CAD
make it easy to recruit participants in research studies.
However, although the prevalence of congenital heart
diseases is increasing dramatically (about 200 millions at
present), there was only 1 related study in the list. In
addition, cardiac tumors, and cardiomyopathies were
virtually unpresented in the list. Therefore, the present
list could help point out the topics and subspecialties
that have not been given due consideration, and should
be the focus of future research.
China’s heavy burden of disease can actually be viewed
as a fruitful clinical resource for physicians to design
clinical research and collect clinical data. However, most
T100 cited papers were focused on basic research. Fur-
thermore, no guidelines were reported in the present
analysis for Mainland China. This differed from other
analyses, in which the leading type of T100 research report
was clinical studies, rather than basic studies [7, 19]. The
status of clinical research in Mainland China might be
attributed to several reasons. First, many physicians do
not have the skills, such as a familiarity with statistical
analysis, to understand and carry out clinical research
to an international standard. In addition, many hospi-
tals in Mainland China do not have mature, integrated
platforms or systems for clinicians to perform clinical
research. In addition, insufficient funding, and a lack of
available time are other important barriers to perform-
ing the clinical researches. Furthermore, many clini-
cians believe that clinical research conflicts with the
accumulation of experience in clinical practice [20].
However, the environment is changing with respect to
these issues. On June 8, 2013, the Chinese Government
officially launched 13 national clinical research centers,
which are led by prominent hospitals with strong clin-
ical experience and research capacities, including two
for cardiovascular diseases [21]. These centers aim to
lead hospitals across China to strengthen their clinical
research capacity, and to organize multicenter clinical
research projects. This development is an important
step in building China’s clinical research capacity. In
the future, there will be a growing amount of important
clinical research done by Chinese physicians, and these
will not only contribute to Chinese clinical practice and
health policies, but will also add to the knowledge that
Fig. 3 Publication type distributions of the T100 articles and the
corresponding numbers of citations
Fig. 4 Research topic distributions of the clinical articles
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is essential for international guidelines. Recently, more
clinical research articles originating from the mainland
China, such as those by Huo Y et al. [22], Li J et al. [23]
and Han Y et al. [24], have been published in high IF
journals and provide important data from Chinese and
international institutes.
Limitations
The present study had several limitations. First, despite a
meticulous search in the web of science database, there is
a chance that some studies were missed. Furthermore, we
only analyzed articles published in the past 10 years, so it
is likely that some truly “classic” articles were excluded. It
is also true that, analysis using other database platforms
such as Scopus or the PubMed Central database, might
lead to a different list. Second, this type of study usually
favors older published articles, while recently published
high quality studies would not be included, a limitation
which is related to the effect of time on citations. Third,
the value of contributions to the field can’t be quantified
only by the number of citations. Therefore, papers that are
important and influential, but have a lower citation fre-
quency, might have been missed. Last, the language of
publication plays a major role, with a bias towards articles
published in English language journals.
Conclusions
Our analysis provides a summary of the most influen-
tial studies on cardiovascular disease originating from
Mainland China from 2004 to 2015, and highlights
areas of research that require further investigation and
development. In addition, Our analysis also provide an
insight into the citation frequency of the top cited arti-
cles published in cardiovascular medicine to shed light
on the quality of the work, discoveries, and the trends
steering cardiology in Mainland China.
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Additional file 1: Bibliometric information associated with the
other 80 articles of the T100. (DOCX 44 kb)
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